The Helsinn Group has become one of the world’s leading supportive cancer care companies, with a comprehensive portfolio of medicines and therapies helping to improve the lives of patients in 90 countries worldwide.

We are committed to developing new treatments, with a growing pipeline of future cancer therapies, including first-in-class therapies that will fulfil more medical needs in the treatment of cancer.

We work with host of longstanding  partners worldwide who share our vision and values, with a unique business model, combining integrated early- and late-stage licensing programmes to complement our own product development.

Damastown Rd, Damastown, Dublin 15, Ireland DB
Tel: +353 1 822 5404